Bio-Rad Laboratories Target Price

Bio-Rad Laboratories (BIO) currently reports a target price of $310. Use the charts on this page to explore Bio-Rad Laboratories's target price history and peer comparisons.

Analysts' average 12-month price target for Bio-Rad Laboratories is $310, about 7.8% downside from the current share price of $332.7. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $310, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bio-Rad Laboratories, and consider following BIO for alerts when major investors trade the stock.

Bio-Rad Laboratories is classified in the Healthcare sector. On target price, it currently shows $310. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BIO with unrelated industries.